Eloxx Pharmaceuticals Inc.
06/08/2026 | Press release | Distributed by Public on 06/09/2026 04:05
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 8, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
|
|||||||
Eloxx Pharmaceuticals Inc. published this content on June 08, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 09, 2026 at 10:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]